Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Veracyte (VCYT) Other Operating Expenses (2016 - 2026)

Veracyte's Other Operating Expenses history spans 14 years, with the latest figure at $26.6 million for Q4 2025.

  • On a quarterly basis, Other Operating Expenses fell 6.39% to $26.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $123.2 million, a 20.63% increase, with the full-year FY2025 number at $123.2 million, up 20.63% from a year prior.
  • Other Operating Expenses hit $26.6 million in Q4 2025 for Veracyte, up from $25.1 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for VCYT hit a ceiling of $59.8 million in Q3 2023 and a floor of -$64.6 million in Q4 2022.
  • Historically, Other Operating Expenses has averaged $34.9 million across 5 years, with a median of $35.7 million in 2021.
  • Biggest five-year swings in Other Operating Expenses: crashed 227.81% in 2022 and later soared 189.47% in 2023.
  • Tracing VCYT's Other Operating Expenses over 5 years: stood at $50.6 million in 2021, then crashed by 227.81% to -$64.6 million in 2022, then soared by 189.47% to $57.8 million in 2023, then crashed by 50.93% to $28.4 million in 2024, then fell by 6.39% to $26.6 million in 2025.
  • Business Quant data shows Other Operating Expenses for VCYT at $26.6 million in Q4 2025, $25.1 million in Q3 2025, and $46.4 million in Q2 2025.